Across Global Alliance Partners with Wemedoo for Clinical Trials
In a significant move to streamline clinical trial management, Across Global Alliance has selected Wemedoo's innovative oomnia® platform as their centralized data management system. This decision is set to enhance collaboration, compliance, and efficiency among the alliance's members working across more than 90 countries.
The strategic partnership marks a pivotal shift in how clinical trials are conducted globally. Across Global Alliance, known for its strategic alliances in clinical research organizations (CROs) and specialized service providers, conducted a comprehensive evaluation of existing data management solutions before arriving at its choice—oomnia. This platform stands out as the only one capable of addressing the intricate operational needs of the alliance's diverse membership base.
At its core, oomnia® integrates essential functionalities necessary for effective management of clinical trials, including Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master Files (eTMF). By consolidating these capabilities into a single cohesive platform, oomnia eliminates the inefficiencies caused by disparate systems and disjointed data workflows, thus paving the way for more effective trial execution.
Steven Bukvic, President of Across Global Alliance, expressed enthusiasm about this partnership, stating, “Conducting global clinical trials requires a system that enables seamless collaboration, eliminates unnecessary delays, and ensures data consistency across all sites. With oomnia, we have found a platform that meets those demands while maintaining regulatory compliance and operational flexibility.” This comments captures the essence of the alliance's goals and the critical needs of their operations.
The implications of this partnership extend far beyond mere efficiency. With oomnia serving as a digital backbone, Across Global Alliance assures all its clients and members that they will benefit from a system designed to maximize trial execution, provide real-time data quality reviews, and offer user-friendly navigation.
Nina Cihoric, CEO of Wemedoo AG, highlighted the transformational aspect of the alliance, saying, “This partnership with Across Global Alliance is another step towards redefining how clinical trials are managed. By offering a truly integrated and adaptable system, we enable alliance members to focus on scientific advancement rather than administrative complexities.” Her words reflect the dedication both organizations have towards enhancing the clinical research landscape.
Across Global Alliance functions as a strategic alliance headquartered in Singapore, bringing together a network of organizations dedicated to clinical research across a plethora of therapeutic areas. The unified infrastructure they offer facilitates smooth coordination, data integrity, and operational excellence in global clinical research. In conjunction with oomnia, they aim to unify efforts and optimize resources, thus improving research outcomes significantly.
On the other hand, Wemedoo AG, based in Switzerland, specializes in data-driven solutions tailored for the healthcare sector. By combining advanced technologies with deep clinical expertise, Wemedoo empowers research teams, CROs, and sponsors to conduct clinical trials more efficiently, leading to reduced costs and accelerated medical innovation. Their commitment to enhancing clinical trial processes aligns perfectly with the mission of Across Global Alliance, and together, they are poised to initiate a paradigm shift in the way clinical trials are conducted worldwide.
This new partnership signifies a move towards efficiency, collaboration, and compliance, making it an exciting development for the clinical research community as it strives to adapt and innovate in an ever-evolving landscape.
For more information on this groundbreaking partnership, please visit
Wemedoo and
Across Global Alliance.